Form 4 for VTAK Catheter Precision, Inc.
Accepted 2023-03-27 00:00:00 ET · period of report 2023-03-23 · accession 0001654954-23-003613 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-27 | 2023-03-23 | VTAK | JENKINS DAVID A | Ex. COB, Dir | C - Cnv Deriv | $0.00 | +277.6K | 277.6K | New | $0 |
| DMI | 2023-03-27 | 2023-03-23 | VTAK | JENKINS DAVID A | Ex. COB, Dir | C - Cnv Deriv | $0.00 | +712.0K | 709.7K | New | $0 |
| D | 2023-03-27 | 2023-03-23 | VTAK | JENKINS DAVID A | Ex. COB, Dir | C - Cnv Deriv | $0.00 | -277.60 | 2,292 | -11% | $0 |
| DMI | 2023-03-27 | 2023-03-23 | VTAK | JENKINS DAVID A | Ex. COB, Dir | C - Cnv Deriv | $0.00 | -711.96 | 18.69 | -97% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-23 | C | A | 277,597 | $0.00 | 277,597 | D See footnote | — | — | (F2) Shares held by a partnership of which the reporting person is the managing member of the managing partner. |
| 2 | Common | Common Stock | 2023-03-23 | C | A | 2,264 | $0.00 | 2,264 | I | — | — | |
| 3 | Common | Common Stock | 2023-03-23 | C | A | 709,703 | $0.00 | 709,703 | I See footnote | — | — | (F3) Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee. |
| 4 | Derivative | Series X Convertible Preferred Stock | 2023-03-23 | C | D | 277.60 | $0.00 | 2,292.34 | D See footnote | $0.00 · — to — | 2,292,339 Common Stock | (F2) Shares held by a partnership of which the reporting person is the managing member of the managing partner. (F4) Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American. (F5) Series X Convertible Preferred Stock has no expiration date. |
| 5 | Derivative | Series X Convertible Preferred Stock | 2023-03-23 | C | D | 709.70 | $0.00 | 5,860.54 | I See footnote | $0.00 · — to — | 5,860,540 Common Stock | (F3) Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee. (F4) Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American. (F5) Series X Convertible Preferred Stock has no expiration date. |
| 6 | Derivative | Series X Convertible Preferred Stock | 2023-03-23 | C | D | 2.26 | $0.00 | 18.69 | I | $0.00 · — to — | 18,691 Common Stock | (F4) Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American. (F5) Series X Convertible Preferred Stock has no expiration date. |